26 62. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, Hodes MZ, Good RA, O’Reilly RJ: Transplantation for severe combined immunodeficiency with HLA-A, -B, -D, -DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983, 61: 341-8. 63. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF: Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998, 339: 1186-93. 64. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science, 2002, 15, 295 (5562): 2097-100. 65. Ji S-Q, Chen H-R, Yan H-M, H-X Wang, J Liu, P-y Zhu, M-h Xiao & C-Q Xunet al. Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical- bone marrow transplantation for hematological malignancies. Bone Marrow Transplant, 2005, 36 (4):349-354. 66. Huang X-J, Liu K-Y, Xu L-P, Chen H, Han W, Chen Y-H, Wang J-Z D-H, Gao Z-Y, Zhang Y-C, Q Jiang, Shi H-X and Lu D-P, Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies Bone Marrow Transplantation 2006, 38: 291–297. 67. Luznik L, O’Donnell PV, Symons HJ, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008, 14(6): 641-650. 68. F.M. Marty, P. Ljungman, R.F. Chemaly, J. Maertens, S.S. Dadwal, R.F. Duarte, S. Haider, A.J. Ullmann, Y. Katayama, J. Brown, K.M. Mullane, M. Boeckh, E.A. Blumberg, H. Einsele, D.R. Snydman, Y. Kanda, M.J. Di Nubile, V.L. Teal, H. Wan, Y. Murata, N.A. Kartsonis, R.Y. Leavitt, and C. Badshah, Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation, N Engl J Med, 2017, 77: 2433-44. 69. Massimo F. Martelli, Mauro Di Ianni, Loredana Ruggeri, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Antonio Pierini, Maria Speranza Massei, Lucia Amico, Elena Urbani, Beatrice Del Papa, Tiziana Zei, Roberta Iacucci Ostini, Debora Cecchini, Rita Tognellini, Yair Reisner, Franco Aversa, Brunangelo Falini, Andrea Velardi, HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood, 2014, 124 (4): 638–644. 70. Alice Bertaina, Pietro Merli, Sergio Rutella, Daria Pagliara, Maria Ester Bernardo, Riccardo Masetti, Daniela Pende, Michela Falco, Rupert Handgretinger, Francesca Moretta, Barbarella Lucarelli, Letizia P. Brescia, Giuseppina Li Pira, Manuela Testi, Caterina Cancrini, Nabil Kabbara, Rita Carsetti, Andrea Finocchi, Alessandro Moretta, Lorenzo Moretta, Franco Locatelli. HLA-haploidentical stem cell transplantation after removal of αß+ T and B cells in children with nonmalignant disorders. Blood, 2014, 124 (5): 822–826. 71. Cytryn S, Abdul-Hay M, Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant, Clinical Hematology International, 2020, 2(2), 49–58. 72. Chang Y-J, Zhao X-Y and Huang X-J, Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective, Front Oncol, 2021, 11: 758512, 1-16. 73. Di Bartolomeo P, Santarone S, De Angelis G, Picardi A, Cudillo L, Cerretti R, Adorno G, Angelini S, Andreani M, De Felice L, Rapanotti MC, Sarmati L, Bavaro P, Papalinetti G, Di Nicola M, Papola F, Montanari M, Nagler A, Arcese W, Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies, Blood 121 (5): 2013, 849–857.
RkJQdWJsaXNoZXIy ODUzNzk5